Tag Archives: PIVKAII

Diagnostic, prognostic and therapeutic relevance of PIVKA-II in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) stays one in all the main causes of cancer-related deaths worldwide, significantly in areas with excessive hepatitis B virus prevalence. As a result of the restricted sensitivity of conventional biomarkers comparable to alpha-fetoprotein (AFP), early detection is difficult. Protein induced by the absence of vitamin Ok or antagonist II (PIVKA-II), an irregular […]